Please login to the form below
Bain Capital
This page shows the latest Bain Capital news and features for those working in and with pharma, biotech and healthcare.
Coronavirus disruption scuppers Curium Pharma sale
Three potential buyers for Curium – said to include investment groups Nordic Capital, Bain Capital and CVC Capital Partners – are said to have lowered their bids for France-based Curium amid turmoil
Latest news
-
Editas CEO exits the CRISPR firm ahead of first clinical trial
managing director at investment group Bain Capital, and a few months after chief medical officer Gerald Cox also stepped down.
-
Pfizer spins out SpringWorks Therapeutics biotech
funding from the drugmaker plus venture capitalists Bain Capital and Orbimed and medical charity LifeArc. ... Pfizer is contributing both equity capital and royalty- and milestone-bearing licenses to the experimental therapies.
-
No deal for Stada as private equity takeover bid collapses
Bain Capital and Cinven's planned buyout of Germany's Stada has failed at the last hurdle, with too few of Stada's shareholders agreeing to the deal by the deadline. ... Stada's board had lent its support to the Bain-Cinven offer over a rival 58 per
-
Private equity firms agree deal to take over Stada
Cinven and Bain Capital beat out competition from Advent International. The board of German pharma company Stada has agreed to a takeover deal with two of three interested private equity companies, ... Cinven and Bain Capital made what Stada said was the
-
Stada opens books to let formal bidding commence
Cinven, Advent International and Bain Capital now have opportunity to revise their bids. ... The three interested parties - confirmed as Cinven, Advent International and Bain Capital - will now all receive the "same level of information" and so have the
More from news
Approximately 2 fully matching, plus 9 partially matching documents found.
Latest Intelligence
-
The changing nature of approvals – what does the future hold?
High-profile disinvestments include those by Pfizer and Eli Lilly. However, Pfizer has since announced that, together with investment firm Bain Capital, it has created a new drug company called Cerevel
-
Deal Watch - May 2017
Innocoll (pharma). 209. Capital International. Minority share. Intas (pharma). 106. Bain and others. ... 4, 750 (incl. debt). Stada (DE). Bain Capital and Cinven. Company acquisition.
-
Deal Watch February 2017
A third suitor is believed to be another PE firm, Bain Capital.
-
Deal Watch February 2016
A couple of weeks later Stryker paid $1.28bn (approximately 2.5 x sales) to buy Physio-Control from Bain Capital. ... Founded in the 1950s, Physio-Control is a pioneer of defibrillator/monitor technologies and was owned by Lilly and then Medtronic before
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- New Omicron sub-variants cause COVID-19 cases to rise in the UK
- Sanofi Global Health unveils new nonprofit Impact brand
- Novartis announces positive phase 3 trial results for advanced oesophageal cancer
- Pfizer announces commitment to achieve Net-Zero Standard by 2040
- My journey advancing the science in pulmonary hypertension
- Dermavant publishes positive phase 3 data for treatment of plaque psoriasis
- The Power of AI in Medical Education
- First evidence-based guide launched to put patients at heart of digital innovations
- FDA grants Priority Review for Biogen and Eisai’s lecanemab for early Alzheimer’s disease
- New Swiss research reveals how Omicron evades the immune system
- Evoke Kyne Named Communiqué Communications Consultancy of the Year 2021
- Michael Grela Elected President of the Society for Health Communication
- Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
- A creative awakening – how pharma is bringing innovation to the patient journey
- EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
- NHS App to revolutionise digital health and care with major digital updates by 2023
- Pfizer/BioNTech, AZ vaccines effective against Delta COVID-19 variant after two doses
- Shionogi Europe and NHS England agree on antibiotic subscription model
PMHub
Frontera Group
A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...
Latest intelligence
- Five big changes in the healthcare comms landscape
- The world of healthcare has changed very greatly in the five years since The Difference Collective launched. Our agile model and talented team have enabled us to keep pace with...
- Early communications in Pharma: How effective pre-approval comms delivers launch success
- What communications are required for a successful launch...
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
